HAEMORRHAGIC CHOLECYSTITIS

HAEMORRHAGIC CHOLECYSTITIS was reported 125 times

HAEMORRHAGIC CHOLECYSTITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Humanized Monoclonal Antibody Fragment [EPC] 1 0.0007
1 P2Y12 Platelet Inhibitor [EPC] 39 0.0003
2 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 4 0.0003
3 Penem Antibacterial [EPC] 5 0.0001
4 Vitamin K [EPC] 1 0.0001
5 Factor Xa Inhibitor [EPC] 31 0.0001
6 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0001
7 Antifibrinolytic Agent [EPC] 1 0.0001
8 Platelet Aggregation Inhibitor [EPC] 41 0.0001
9 Radiographic Contrast Agent [EPC] 1 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 46 0.0000
11 Prostacycline Vasodilator [EPC] 4 0.0000
12 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 3 0.0000
13 Fluoroquinolone Antibacterial [EPC] 2 0.0000
14 Nitroimidazole Antimicrobial [EPC] 1 0.0000
15 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
16 Aldosterone Antagonist [EPC] 2 0.0000
17 Corticosteroid [EPC] 16 0.0000
18 Nitrate Vasodilator [EPC] 1 0.0000
19 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
20 Purine Antimetabolite [EPC] 1 0.0000
21 Insulin Analog [EPC] 4 0.0000
22 alpha-Adrenergic Blocker [EPC] 1 0.0000
23 Proton Pump Inhibitor [EPC] 4 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
25 Estrogen [EPC] 1 0.0000
26 Loop Diuretic [EPC] 2 0.0000
27 Opioid Agonist [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000